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Summary A series of 60 primary laryngeal and hypopharyngeal tumours, 24 lymph node metastases and
normal tissue were evaluated in frozen sections for the expression of MHC class I antigens, using monoclonal
antibodies and the APAAP technique. We found 13 tumours presenting total HLA-ABC loss, five with
selective loss of HLA-A antigens and one with absence of HLA-B antigens. These losses were statistically
associated with clinical and pathological parameters, such as T stage, degree of differentiation, scores
according to the Jakobsson and Glanz grading systems and degree of leukocytic infiltration. Our results lead
us to the following conclusions: (a) HLA class I losses were found in a group of tumours showing greater
aggressiveness and worse prognosis; (b) these alterations in expression were not associated with an increased
metastatic potential. Thus, the absence of HLA molecules in laryngeal tumours is related to greater local
aggressiveness, and the loss of class I antigens seems to constitute an adaptive tumour mechanism to avoid the
different anatomical and immunological barriers within the larynx.
MHC antigens (H-2 in mice and HLA in man) are mem-
brane glycoproteins which are involved in different
immunological phenomena. Specifically, effective T and B cell
activation requires MHC class II compatibility between
macrophages and T cells, and effective killing by cytotoxic T
cells may require HLA class I compatibility between T cells
and target cells (i.e. virus-infected and tumour cells)
(Thorsby, 1982; Festenstein & Garrido, 1986). Class I
antigens are composed of a highly polymorphic heavy chain
associated non-covalently to P2-microglobulin. MHC class I
and II antigens are required for peptide presentation to the
immune system, including peptides acting as tumour antigens
(Townsend et al., 1985). Alterations in HLA-ABC expression
may be one way used by cancer cells to avoid immune
destruction (Garrido, 1987). Decreased HLA expression has
been discovered in several human tumours, including breast,
skin, colorectal, gastric and laryngeal carcinomas (L6pez-
Nevot et al., 1986, 1989; Ruiz-Cabello et al., 1989). However,
few studies have analysed the mechanisms responsible for
such alterations. In previous papers we investigated changes
in the expression of HLA class I antigens during malignant
transformation of the laryngeal epithelium, and some of the
mechanisms involved (Esteban et al., 1989). MHC class II
antigens were only found in verrucous cell carcinomas, thus
DR expression seem to be associated with tumours with
excellent prognosis (Esteban et al., 1990). The objective of
the present work is to analyse further the group of tumours
in which such alterations were found, from both clinical and
pathological approaches, to evaluate the prognostic
significance of MHC class I antigens in patients with
laryngeal carcinoma.
Materials and methods
Patients
Sixty patien s with squamous cell carcinoma of the larynx
were included in the study. None of them received
radiotherapy or chemotherapy prior to surgery. All were
male. Age ranged from 44 to 75 years (average 58.68).
Tumours were classified as originating from the supraglottic
region (33; 55%), glottis (18; 30%), subglottis (2; 3.3%) and
pyriform sinus (3; 5%). Four cases were considered transglot-
tic (6.7%).
Surgical techniques consisted in cordectomy (four cases),
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frontolateral laryngectomy with epiglottoplasty as first de-
scribed by Sedlacek and popularised by Tucker (1976) (two
cases), partial horizontal supraglottic laryngectomy (12 cases)
and total laryngectomy (42 cases). Twenty-two patients
underwent ipsilateral and 18 bilateral functional neck dissec-
tion. Radical ipsilateral neck dissection was performed in
three patients, and a bilateral procedure in four. Follow-up
ranged from 12 to 48 months. At present, ten patients have
died of laryngeal cancer, and one is alive with disease. Two
cases were lost to follow-up. In each case we recorded the
location and diameter of the primary tumour, T and N
pathological staging (Kleinsasser, 1987), number of lymph
nodes from the neck dissection and number of lymph node
metastases, pathological staging, blood group and Rh of the
patient, age, smoking and alcohol consumption, first
symptom-diagnosis interval and follow-up (in months).
Pathological analysis
Tumours were classified into three grades (UICC modified
Broders' system (Wahi, 1972)) and all were scored according
to Glanz's (1984) and Jakobsson's (Jakobsson et al., 1973)
grading systems for squamous cancer. In addition, two
modifications to the former were included (Crissman et al.
(1984) and the authors' modification). The histologic grade of
malignancy was based upon the tumour cell population
(structure, differentiation, nuclear polymorphism, mitoses)
and tumour-host relationship (mode of invasion, stage of
invasion, vascular invasion, cellular response). Histological
analyses were performed without any knowledge of the
clinical stage, treatment, or further course of the disease.
Immunohistochemical analysis
The immunohistochemical technique and monoclonal
antibodies used were described in a previous publication
(Esteban et al., 1989). A tumour was classified as negative
when no staining was detected in any of ten randomly chosen
microscopic fields, and as positive when all tumour cells were
stained in ten fields. In our series, no specimens showed
heterogeneous pattern of staining for the HLA-ABC
antigens.
Statistical analysis
The mean and standard deviation of each pathological and
clinical parameter were computed. HLA (+) tumours and
HLA (-) tumours were compared to by a t test. Statistical
correlations were calculated using the BMDP package from
UCLA (1985 version).
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Figure I A HLA class I positive tumour, presenting
homogeneous staining with the W6/32 monoclonal antibody
against the heavy chain of class I antigens. APAAP technique
(x 137.5).
Figure 2 HLA class I negative laryngeal carcinoma. Positivity
was limited to the stromal cells and tumour infiltrating
leukocytes. GRHI monoclonal antibody against P2-
microglobulin. APAAP technique (x 137.5).
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Results
Normal laryngeal mucosa was always positive for HLA-ABC
antigens. Losses of these antigens were always related to
malignancy. In Figure 1 we present an example of well
differentiated squamous cell carcinoma of the larynx, show-
ing homogeneous staining for the W6J32 monoclonal
antibody against the heavy chain of HLA'class I antigens.
Forty-one carcinomas were considered positive for class I
antigens.
We found 13 total losses of HLA-ABC antigens, as
revealed by the W6/32 and GRH1 monoclonal antibodies
(Figure 2), five selective losses of HLA-A (anti-HLA-A
MAb) and one of HLA-B antigens (anti-HLA-B). Our
analysis of class I expression in tumours and autologous
lymph node metastases (15 cases) detected four cases present-
ing divergencies: in two cases the primary tumour was
negative and the metastases positive, and in one case the
metastases were negative while the tumour was positive. The
fourth tumour was negative, but the metastases presented
selective loss of HLA-B antigens. We should point out that
in two cases selective loss of HLA-A antigens was found not
only in the primary tumour but also in the metastases.
Pathological parameters
When comparing HLA-ABC (-) tumours with the HLA-
ABC (+) group, we found a clear relationship between class
I expression and degree of differentiation. HLA-ABC (-)
tumours presented a worse differentiation, based on Broders'
(Figure 3), Jakobsson's or Glanz's grading systems (Table I).
The study of the pathological parameters between groups
also yielded differences (Table II).
Clinical parameters
The clinical parameters significantly associated with the loss
of class I antigens are shown in Table III. We excluded
tumours of the pyriform sinus from our analysis, as they
present a different biological behaviour, and most series con-
sider them separately. The comparison of the mean interval
between first symptom and diagnosis also yielded significant
differences.
The relationship between HLA-ABC losses (total and
selective losses) and metastatic potential is shown in Figure 4.
The P value was 0.1771. In this analysis we excluded both
pyriform sinus carcinomas and verrucous carcinomas in
order to work with a homogeneous group.
Most class I negative tumours were classified as advanced
stages (Figure 5). We found a close relationship between class
I expression and staging of the cases, most of the negative
class I tumours being stage IV (9 out of 12). As there was no
significant association between metastatic potential and class
I losses, it seems that HLA class I negative tumours were
bigger and grew deeper than those in the positive group. At
present, ten patients had died of disease, and six of them had
tumours presenting total or selective loss of HLA-ABC
antigens.
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Figure 3 Relationship between HLA class I expression and
degree of differentiation in our series. P= 0.001.
Discussion
Because of the central role of class I and II molecules in the
Table I Comparison of HLA (+) and (-) tumours: grading systems
System Cases (+) S.d.a Cases (- )C s.d. Significance
Broders 1.634 0.79 2.462 0.66 P = 0.001
Jakobsson 17.51 4.88 23.08 3.90 P = 0.0003
Jakob. mod.d 13.73 4.64 19.08 3.90 P = 0.0004
Jakob. mod.' 15.59 4.25 20.19 3.25 P = 0.0003
Glanz 5.02 2.20 6.92 1.55 P = 0.0018
'Standard deviation. bHLA (+) tumours (41 cases). CHLA (-) tumours
(13 cases). dCrissman et al. (1980). 'Authors' modification including 'overall
cellular differentiation'.LARYNX SQUAMOUS CELL CARCINOMA 1049
Table II Comparison of HLA (+) and (-) tumours: pathological
parameters
Parameter Tumours (+)a Tumours (-)" Significance
Jakobssonc
Differentiationd 1.872 2.769 P = 0.0049
Nuclear atypia 1.897 2.846 P = 0.0016
Number of mitosis 2.026 2.692 P = 0.0163
Structure 1.744 1.899 P = 0.5525*
Pattern of invasion 1.699 2.000 P = 0.4484*
Vascular invasion 2.154 3.538 P = 0.0053
Lymphoid response 1.872 2.308 P = 0.0600*
Stage of invasion 3.769 4.000 P = 0.1441*
Differentiation' 1.897 2.885 P = 0.0011
Glanz
Differentiation 1.667 2.462 P = 0.0022
Structure and margins 1.385 1.538 P =0.3751*
Vascular/perineural infiltration 1.000 1.615 P = 0.0154
Infiltrate 0.846 1.385 P = 0.0273
*No significance was found. IHLA (+) tumours. bHLA (-) tumours.
cParameters included in Jakobsson's grading system and its modifications.
dDifferentiation of the tumour (keratin formation). 'Cellular differentiation.
No 28
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Class I (+)
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Class I (-)
P >0.1
Verrucous/pyriform sinus tumors excluded
Figure 4 Relationship between HLA class I expression and
metastatic potential of the tumours.
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Figure 5 Relationship between HLA class I expression and stag-
ing of the tumours.
immune system, it is not surprising that alterations in their
expression could affect the immunosurveillance against
tumours. During the cytotoxic-T-lymphocyte-mediated re-
sponse, the neoplastic antigen associated with class I pro-
ducts interact with the T cell receptor (TCR), thus changes in
the expression of histocompatibility antigens may affect the
immune response against malignant neoplasms, their growth
rate and metastatic potential. The expression of these
molecules may therefore be one of the factors responsible of
oncogenicity, due to their role as restriction elements in T cell
recognition (Zinkernagel & Doherty, 1979).
Although our studies do not elucidate the molecular basis
of the defect in expression of class I antigens, regulatory
mechanisms, rather than genetic rearrangements, are likely to
be involved in these phenomena, as shown by the results of
the southern blotting analyses in our series (Esteban et al.,
1989). In fact, in many human tumours with undetectable
levels of class I antigen expression, HLA expression has been
induced by exposing the neoplastic cells to t-interferon
(Ruiz-Cabello et al., 1988, 1989). Further evidence support-
ing the hypothesis that regulatory mechanisms are involved
in the control of the expression of MHC products comes
from oncogene studies. The amplification of c-myc has been
shown to correlate with low levels of class I molecules (Doyle
et al., 1985), and other studies in neuroblastoma (Lamson et
al., 1983) and melanoma cell lines (Versteeg et al., 1988) have
also found an association between c-myc and N-myc
amplification and a decrease in class I molecule expression.
These authors claim that repression of the expression may be
a common feature in oncogene-mediated malignant trans-
formation.
Our comparative analysis of tumours with total loss of
MHC class I antigen expression with tumours showing levels
of expression considered normal suggest a number of con-
clusions. To assess the malignancy of these tumours, because
of the short follow-up period (12-48 months), we used the
criteria of Jakobsson et al. (1973) with two modifications
(Crissman et al. (1984) and our own modification) and
criteria established by Glanz (1984). As described in Table II,
Table III Clinicopathological parameters: HLA class I (+) and (-) tumours
Parameter' Cases (+ ) s.d.e Cases (- )c s.d. Significance
T stage 2.872 0.80 3.538 0.51 P=0.0014
First symptom- 15.71 23.73 4.583 4.14 P =0.0091
diagnostic intervald
Pathological staging 2.949 0.85 3.769 0.43 P = 0.0001
aMean of values for each parameter. Tumours of the pyriform fossa were
excluded. bGroup of HLA (+) tumours. cClass I negative tumours. dIn months.
eStandard deviation.1050 F. ESTEBAN et al.
the loss of HLA class I antigen expression is associated with
tumours of worse prognosis according to the grading systems
employed. When analysing the different pathological
parameters used and their significance values, lower P values
were obtained in association with nuclear atypia, vascular
invasion and overall cellular differentiation (Table II). The
strong association with vascular invasion was somewhat
amazing, as tumours with altered class I expression have not
been significantly associated with the presence of metastases
(Figure 4). We should however point out that vascular
invasion itself has been linked with an ominous prognosis
(Poleksic & Kalwaic, 1978). Tumour cell lysis mediated by
NK cells could be an explanation of this finding.
Another apparent discrepancy was that tumours with
altered class I expression were not significantly associated
with advanced stages ofhistopathological invasion (Table II),
whereas the association was evident with advanced
clinicopathological invasion (P = 0.0001; Table III). This
may be derived from the grading systems used, as most
tumours were classified as showing 'deep infiltration',
whereas they differed clearly enough to be categorised as T3
or T4 when studying the surgical specimens.
On the other hand, we have observed that the loss of class
I antigens is strongly associated with the degree of
differentiation (Figure 3), a phenomenon also noted in other
carcinomas, i.e. colon carcinomas (Momburg et al., 1986).
There was a clear relationship between loss ofclass I antigens
and the different grading systems of malignancy employed, as
described in Table I. When analysing the different parameters
which ar,e considered to reflect the differentiation of the
tumour cell, the strongest association for class I tumours was
found with the parameter that we called 'overall cellular
differentiation; (P = 0.0011). A less marked but still high
significant association was noted for cytoplasmic
differentiation (keratin formation) (Table II).
There was a strong relationship between the absence or
selective loss of class I molecules and the T stage (TNM
classification), but not with maximum diameter of the neo-
plasm, suggesting that the main factor was degree of deep
invasion of the tumour rather than superficial spreading. This
phenomenon has also been observed in malignant melanoma
(Brocker et al., 1985) and may be explained in terms of
'tumour' progression', i.e. the natural history of spontaneous
tumours being a multistep process in which new clones re-
place their precursors as a result of selection (Cairns, 1975;
Klein & Klein, 1985). The loss of class I antigen expression
associated with advanced T stages may result from
phenotypical changes which benefit the neoplastic cell
growth. In this way, the classical studies of the different
anatomical and biochemical laryngeal barriers are of
significance (Tucker, 1976; Kirchner & Carter, 1987).
Moreover, in contrast to the large number of studies relating
the degree of differentiation to metastatic potential (see for
review in Glanz, 1984), only a limited number ofpublications
have linked larger tumours with higher rates of metastasis
(McGavran et al., 1961; Kirchner et al., 1974; Pera et al.,
1986). The analysis of tumours using the different grading
systems ofmalignancy seems to point toward a gradient from
positive tumours with lower scores and better prognosis, to
HLA-ABC negative tumours, being a intermediate group the
neoplasms with selective losses of HLA-A or HLA-B
antigens (data not shown). It is interesting to remark the
other clinicopathological parameters associated with altera-
tions in class I expression. Duration of symptoms is an
indirect measure of tumour aggressiveness, or at least of the
rate of neoplastic growth. Notably, class I negative tumours
also exhibited a short first symptom-diagnosis interval
(Table III) with a significant difference between negative
(mean 4.5 months) and positive tumours (mean 15.7 months,
P = 0.0091). Thus, class I negative tumours seem to show a
highly aggressive histopathological profile, as shown by the
significance found in all the grading systems used, as well as
on the basis of clinical criteria, i.e. association with advanced
T stage and short first symptom-diagnosis interval, and
worse prognosis as reflected by the patient's status.
In conclusion, the association between loss of HLA-ABC
expression and a number of parameters related to tumour
aggressiveness supports the hypothesis that the study of class
I expression in laryngeal cancer may be considered of clinical
value. A negative result for class I antigen expression may
indicate deep infiltration by the tumour, which could be
difficult to detect before surgery has been performed. Further
investigations will be needed to ascertain the role of HLA
antigens in the immunobiology of laryngeal squamous cell
carcinoma, being follow-up studies necessary to evaluate the
prognostic significance of the alterations in class I antigen
expression.
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